Your browser doesn't support javascript.
loading
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar.
Kim, Eunji; Han, Jihyeon; Chae, Yunjung; Park, Hyerim; Kim, Saerom; Kim, Seokkyun; Lee, Jungmin; Kim, Beom Chan.
Afiliação
  • Kim E; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Han J; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Chae Y; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Park H; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Kim S; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Kim S; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Lee J; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea.
  • Kim BC; Quality Evaluation Team, Samsung Bioepis Co., Ltd, Incheon, South Korea. beomchan.kim@samsung.com.
Ophthalmol Ther ; 11(2): 639-652, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35084693
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul